Global Market Study on Malignant Mesothelioma

We have used our in-house epidemiology data based model to estimate the global malignant mesothelioma market numbers

Weighted average selling price has been considered to estimate the market size of various drugs mentioned in the scope of the study. Price per country is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard. We have also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions. Prices considered in the models are standardized based on the average dosage used per malignant mesothelioma treatment per dosage cycle of six months. Availability of branded off-patent equivalents has been taken into consideration while calculating prices. We have adopted the bottom-up approach to forecast the malignant mesothelioma market globally. Besides this, forecasting is done using our internal proprietary model that considers different macro-economic factors, industry based demand driving factors impacting the market and the relevant forecast trends apart from disease related factors.

Market Taxonomy

Drug Type

• Pemetrexed
• Cisplatin
• Carboplatin
• Gemcitabine
• Vinorelbine
• Others

Route of Administration

• Oral
• Parenteral

Region

• North America
• Latin America
• Europe
• APAC
• MEA

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Oncology Centers

Research Methodology

Our research methodology leverages both primary and secondary research to collect the relevant market data. We have analyzed the global malignant mesothelioma market by considering key player revenue, usage patterns, historic trends, and problems faced by oncologists, the required treatment developments, and most preferred drugs. Key opinion leaders including experienced healthcare professionals in various healthcare facilities at the country level have been considered for primary research. These estimates have been further validated with drug manufacturers, distributors, and suppliers. Extensive secondary research has been carried out to understand the epidemiology of malignant mesothelioma, treatment rate, adoption rate, regulatory scenarios, average selling price and the global reimbursement scenario by referring to published scientific literature from various databases such as the WHO, Asbestos.com, PubMed, Springer, and Wiley among many others. We have also analyzed the various companies’ annual reports, investor presentations, SEC filings, reports and press releases to fetch substantial information pertaining to the market size, trends, opportunities, drivers, and restraints.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.